About Pharma Industry

BNET Pharma provides daily industry trends and news coverage with insights for managers and executives about major manufacturers of pharmaceuticals and medicine. In addition to detailed drug company profiles, we bring you industry analysis on new partnerships, drug patents and products, cost management, investments, pharmaceutical related lawsuits, and a host of other important business issues.

Pfizer's New Cancer Drug for Dogs Is Mixed News for Rover

By Jim Edwards | Jun 3, 2009

Pfizer will launch a new cancer treatment for dogs. The oral drug, Palladia, will help fight mast cell tumors, often seen as skin lumps. This is a good news/bad news situation for dogs.

First, older dogs often get fat lumps on their skin that are harmless. With Pfizer’s publicity for Palladia, many owners will drag their dog to the vet to see if those lumps are cancer or not. Dogs are just going to love that.

Second, Palladia does not cure dog cancer. It merely treats it. Pfizer says:

… 60% of dogs had their tumors disappear, shrink or stop growing…

Meaning Palladia can shrink tumors, but only until they start growing again. In fact, dogs with systemic tumors were excluded from the study. Read the details in the PI. This may extend your dog’s life, but check out the side effects seen in dogs on Palladia:

  • Diarrhea 46.0%
  • Anorexia 39.1%
  • Lethargy 35.6%
  • Vomiting 32.2%
  • Lameness 17.2%
  • Weight loss 14.9%

All these effects were higher than in dogs on placebo (except for vomiting) — so they’re not a result of the cancer.

It raises a question that Americans frequently get wrong when it comes to their pets: When my dog gets sick, what is the best thing to do? Most people answer a) “Everything humanly possible.” But the correct answer should frequently be b) “Everything you can, but only until the dog becomes so unhappy that putting him to sleep is better.”

So this drug could, potentially, put a lot of dogs through some unnecessary pain.

Separately: Interesting choice of brand name, Pfizer pfolks! It’s already the name of a social services organization in New York and MTV’s new hi-def music channel.

Jim Edwards, a former managing editor of Adweek, has covered drug marketing at Brandweek for four years, and is a former Knight-Bagehot fellow at Columbia University's business and journalism schools. Follow him on Twitter or send him an email.

BNET User Analysis

Web Buzz:
  • Pfizer's new cancer drug for dogs wins approval

    FierceMarkets - 172 days 13 hours 47 minutes ago

    Pfizer has won approval for a new cancer drug for dogs with the kind of clinical data most developers can only dream about. The FDA approved Palladia to treat advanced mast cell tumors in dogs, the first cancer therapy OK#039d for canines. Researchers recruited 150 dogs for the pivotal pet study, and found that Palladia triggered the...

  • Dogs wagging tails over approval of their first cancer medicine

    iTWire - 169 days 13 hours 3 minutes ago

    The U.S. Food and Drug Administration approved a skin-tumor cancer drug, Palladia, especially for dogs. Its use will greatly improve the health and well-being of our four-legged friends. Currently treated with human-related cancer drugs, this drug will more effectively treat skin tumor cancer within dogs

  • Merck suffers as CHMP nixes Erbitux use

    Fierce Pharma - 122 days 13 hours 32 minutes ago

    It was a bad news-bad news sort of day for Merck KGaA. European regulators unexpectedly rejected the company's Erbitux cancer treatment as a remedy for non-small cell lung cancer. And the company reported that second-quarter profits plummeted by 48 percent. Then, Merck stock fell 16 percent, making it a bad news trifecta. The Committee for Human...

  • Hard Times for Nonprod Workers in Manufacturing

    BusinessWeek - 28 days 14 hours 12 minutes ago

    Posted by: Michael Mandel on October 26 Here’s a bit of a good news-bad news chart. The rate of job cuts for production workers in manufacturing has slowed dramatically in the past few months, as companies start to rebuild inventories. However, they are still aggressively slicing their nonproduction workers—engineers, managers, sales staff,...

  • FDA Aggressively Targets Herbal Cure Websites

    NaturalNews - 326 days 20 hours 39 minutes ago

    (NaturalNews) The FDA has sent letters to 25 companies, threatening them with disciplinary action if they do not stop claiming that their herbal products can prevent or cure cancer. The agency identified a total of 125 "tablets, teas, tonics, black salves and creams" that made prohibited claims, including "shrinks malignant tumors;" "treats all...

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement